Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 2
---
 to the STAAR stockholders for adoption at the special meeting.

The Board unanimously recommends that you vote: (1) “FOR” the Merger Proposal and (2) “FOR” the Compensation Proposal.The Board may, at its discretion, adjourn or postpone the special meeting to a later date or date(s), including for the purpose of soliciting additional proxies.

Your vote is very important regardless of the number of shares of STAAR common stock that you own. Broadwood Partners, L.P. and certain of its affiliates (collectively, “Broadwood Group”) have filed a preliminary proxy statement in connection with the special meeting. We recommend that STAAR stockholders disregard any proxy card sent to them by or on behalf of any person other than STAAR, including any green proxy card and solicitation materials that may be sent to STAAR stockholders by or on behalf of Broadwood Group. If you have submitted such a proxy card (including a green proxy card), we ask that you recast your vote as instructed on the WHITE proxy card mailed to you by STAAR, which will revoke any earlier dated proxy card that you submitted. Only the last validly executed proxy that you submit will be counted and such proxy will be counted only if it has been received by 11:59 p.m., Eastern Time, on October 22, 2025. Whether or not you plan to attend the special meeting, please submit your proxy as soon as possible by following the instructions on the accompanying WHITE proxy card to make sure that your shares are represented at the meeting. If your shares are held in the name of a broker, bank or other nominee, please follow the instructions on the voting instruction form furnished by the broker, bank or other nominee. You must provide voting instructions by filling out the voting instruction form in order for your shares to be voted. The special meeting will be held in a virtual meeting format only. You will not be able to attend the special meeting physically in person. The proxy statement for the special meeting, which both summarizes the Merger Agreement and attaches a copy thereto, is attached to this notice, and incorporated by reference into this notice. Thank you for your continued support. Sincerely,

| Stephen C. Farrell      |     | Elizabeth Yeu, M.D. |
| Chief Executive Officer |     | Board Chair         |

Neither the U.S. Securities and Exchange Commission nor any state securities regulatory agency has approved or disapproved the Merger, passed upon the merits or fairness of the Merger or passed upon the